Qulipta (atogepant)

pCPA File Number: 22777
Negotiation Status:
Concluded with an LOI
Indication(s):
Migraine, prevention
Sponsor/Manufacturer:
AbbVie Corporation
CDA-AMC Project Number:
SR0817-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: